Chargement en cours...
The evolving role of FLT3 inhibitors in acute myeloid leukemia: quizartinib and beyond
Acute myeloid leukemia remains associated with poor outcomes despite advances in our understanding of the complicated molecular events driving leukemogenesis and malignant progression. Those patients harboring mutations in the FLT3 receptor tyrosine kinase have a particularly poor prognosis; however...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4031904/ https://ncbi.nlm.nih.gov/pubmed/24883179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620714532123 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|